Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33903101932;101933;101934 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
N2AB3226297009;97010;97011 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
N2A3133594228;94229;94230 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
N2B2483874737;74738;74739 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
Novex-12496375112;75113;75114 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
Novex-22503075313;75314;75315 chr2:178534908;178534907;178534906chr2:179399635;179399634;179399633
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: CGC
  • RefSeq wild type template codon: GCG
  • Domain: Kinase-1
  • Domain position: 91
  • Q(SASA): 0.0939
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/C rs772574722 -2.078 None N None 0.403 0.754502143824 gnomAD-2.1.1 4.69E-05 None None None None N None 1.24131E-04 2.83E-05 None 0 5.13E-05 None 6.54E-05 None 0 3.91E-05 1.41283E-04
R/C rs772574722 -2.078 None N None 0.403 0.754502143824 gnomAD-3.1.2 3.94E-05 None None None None N None 7.24E-05 6.54E-05 0 0 0 None 0 0 2.94E-05 0 0
R/C rs772574722 -2.078 None N None 0.403 0.754502143824 gnomAD-4.0.0 2.60895E-05 None None None None N None 4.00566E-05 8.335E-05 None 0 2.22816E-05 None 0 0 2.45809E-05 2.19578E-05 3.20328E-05
R/H rs72629782 -2.243 None N None 0.447 None gnomAD-2.1.1 2.41827E-04 None None None None N None 8.27E-05 0 None 0 1.99979E-03 None 3.27E-05 None 7.63839E-04 6.26E-05 0
R/H rs72629782 -2.243 None N None 0.447 None gnomAD-3.1.2 1.90576E-04 None None None None N None 2.41E-05 0 0 0 1.92382E-03 None 1.41429E-03 0 4.41E-05 0 0
R/H rs72629782 -2.243 None N None 0.447 None 1000 genomes 5.99042E-04 None None None None N None 0 0 None None 3E-03 0 None None None 0 None
R/H rs72629782 -2.243 None N None 0.447 None Huang (2021) None Other comp het with T2014A (in cis), c.1800+1G>A (in trans) None None N Genetic analysis of NMD patients; variant prioritisation; no validation None None None None None None None None None None None
R/H rs72629782 -2.243 None N None 0.447 None gnomAD-4.0.0 9.25565E-05 None None None None N None 3.99808E-05 0 None 0 1.09204E-03 None 7.82838E-04 1.65017E-04 3.64475E-05 1.09803E-05 8.00512E-05
R/L rs72629782 None None N None 0.489 0.684638531588 gnomAD-4.0.0 1.37218E-06 None None None None N None 0 0 None 0 0 None 0 0 1.79896E-06 0 0
R/S None None None N None 0.39 0.547470054201 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
R/S None None None N None 0.39 0.547470054201 gnomAD-4.0.0 2.48471E-06 None None None None N None 0 0 None 0 0 None 0 0 3.39047E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.8749 likely_pathogenic 0.8612 pathogenic -2.295 Highly Destabilizing None None None None None None None None N
R/C 0.7067 likely_pathogenic 0.6083 pathogenic -2.105 Highly Destabilizing None None None None N 0.51870338 None None N
R/D 0.939 likely_pathogenic 0.932 pathogenic -0.895 Destabilizing None None None None None None None None N
R/E 0.7724 likely_pathogenic 0.7359 pathogenic -0.671 Destabilizing None None None None None None None None N
R/F 0.9559 likely_pathogenic 0.9396 pathogenic -1.658 Destabilizing None None None None None None None None N
R/G 0.7916 likely_pathogenic 0.7555 pathogenic -2.639 Highly Destabilizing None None None None N 0.514489639 None None N
R/H 0.442 ambiguous 0.3726 ambiguous -2.31 Highly Destabilizing None None None None N 0.459463076 None None N
R/I 0.8061 likely_pathogenic 0.764 pathogenic -1.289 Destabilizing None None None None None None None None N
R/K 0.3272 likely_benign 0.275 benign -1.193 Destabilizing None None None None None None None None N
R/L 0.7441 likely_pathogenic 0.686 pathogenic -1.289 Destabilizing None None None None N 0.446915066 None None N
R/M 0.8163 likely_pathogenic 0.7444 pathogenic -1.702 Destabilizing None None None None None None None None N
R/N 0.893 likely_pathogenic 0.885 pathogenic -1.255 Destabilizing None None None None None None None None N
R/P 0.9802 likely_pathogenic 0.9769 pathogenic -1.615 Destabilizing None None None None N 0.499718434 None None N
R/Q 0.3684 ambiguous 0.2977 benign -1.209 Destabilizing None None None None None None None None N
R/S 0.9221 likely_pathogenic 0.9098 pathogenic -2.329 Highly Destabilizing None None None None N 0.491612779 None None N
R/T 0.8256 likely_pathogenic 0.7992 pathogenic -1.878 Destabilizing None None None None None None None None N
R/V 0.8602 likely_pathogenic 0.8215 pathogenic -1.615 Destabilizing None None None None None None None None N
R/W 0.7518 likely_pathogenic 0.6528 pathogenic -1.06 Destabilizing None None None None None None None None N
R/Y 0.8715 likely_pathogenic 0.8251 pathogenic -0.953 Destabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.